Competitive Inhibition by Danazol of Progesterone and Dihydrotestosterone Binding to Human Uterine Progestin and Androgen Receptors

This short communication studied whether danazol can interfere with hormone binding by testing competitive inhibition effects on progesterone and dihydrotestosterone binding to human uterine progestin and androgen receptors. In binding assays, danazol was found to competitively inhibit progesterone binding and dihydrotestosterone binding to these respective receptor types, indicating overlapping interference at the receptor level. The authors present limited experimental detail consistent with a brief report, without extending findings to clinical outcomes or uterine tissue function. Relevance to endometriosis: the paper examines danazol’s interaction with uterine hormone receptors, which is historically relevant to endometriosis treatment mechanisms though the article itself is focused on receptor binding rather than endometriosis pathology.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works